Medicare Enrolled
Dr. Aziz Kamali, M.D.
Geriatric Medicine (Internal Medicine) Physician · Stockton, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kamali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kamali
Dr. Aziz Kamali is a geriatric medicine physician in Stockton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kamali performed 1,875 Medicare services across 776 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kamali received a total of $21,252 from 68 pharmaceutical and/or device companies across 1254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in geriatric medicine (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in CA
$21,252 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,875
Medicare services
Top 25% in CA for geriatric medicine (internal medicine) physician
776
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
799 | $33 | $136 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
470 | $98 | $443 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
301 | $68 | $332 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
78 | $123 | $557 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
45 | $9 | $80 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
38 | $29 | $220 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
37 | $1 | $23 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
24 | $124 | $331 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
21 | $32 | $105 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
19 | $40 | $226 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
16 | $22 | $119 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
14 | $95 | $320 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
13 | $4 | $27 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,252
Total received (2018-2024)
Avg $3,036/year across 7 years
Top 4% in CA for geriatric medicine (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,254
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,252 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,361
2023
$2,904
2022
$3,192
2021
$3,048
2020
$3,393
2019
$2,208
2018
$3,145
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$475
AstraZeneca Pharmaceuticals LP
$445
Boehringer Ingelheim Pharmaceuticals, Inc.
$392
UCB, Inc.
$309
Corcept Therapeutics
$250
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$194
Lilly USA, LLC
$169
Phathom Pharmaceuticals, Inc.
$143
Ardelyx, Inc.
$129
Otsuka America Pharmaceutical, Inc.
$122
GlaxoSmithKline, LLC.
$93
IRONWOOD PHARMACEUTICALS, INC
$77
PFIZER INC.
$67
Vanda Pharmaceuticals Inc.
$65
OPKO Pharmaceuticals, LLC
$55
Merck Sharp & Dohme LLC
$55
Novartis Pharmaceuticals Corporation
$46
Novo Nordisk Inc
$46
Teva Pharmaceuticals USA, Inc.
$45
Neurocrine Biosciences, Inc.
$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Kowa Pharmaceuticals America, Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$19
E.R. Squibb & Sons, L.L.C.
$17
ABBVIE INC.
$15
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,831
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,958
AstraZeneca Pharmaceuticals LP
$1,267
Janssen Pharmaceuticals, Inc
$1,133
Sunovion Pharmaceuticals Inc.
$961
PFIZER INC.
$957
UCB, Inc.
$818
Neurocrine Biosciences, Inc.
$799
Sumitomo Pharma America, Inc.
$782
Lilly USA, LLC
$780
ABBVIE INC.
$690
Novartis Pharmaceuticals Corporation
$640
GlaxoSmithKline, LLC.
$510
Teva Pharmaceuticals USA, Inc.
$484
Avanir Pharmaceuticals, Inc.
$428
Amarin Pharma Inc.
$379
Merck Sharp & Dohme Corporation
$329
AbbVie Inc.
$298
SANOFI-AVENTIS U.S. LLC
$295
Amgen Inc.
$255
Corcept Therapeutics
$250
Forte Bio-Pharma LLC
$247
Allergan, Inc.
$237
Xeris Pharmaceuticals, Inc.
$215
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$212
Merck Sharp & Dohme LLC
$202
RedHill Biopharma Inc.
$201
Gilead Sciences, Inc.
$195
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$194
Takeda Pharmaceuticals U.S.A., Inc.
$190
IDORSIA PHARMACEUTICALS US INC
$182
Biohaven Pharmaceuticals, Inc.
$177
Ironwood Pharmaceuticals, Inc
$174
Becton, Dickinson and Company
$161
IRONWOOD PHARMACEUTICALS, INC
$153
Otsuka America Pharmaceutical, Inc.
$146
Phathom Pharmaceuticals, Inc.
$143
Ardelyx, Inc.
$129
Biohaven Pharmaceutical Holding Company Ltd.
$126
Hikma Pharmaceuticals USA
$97
Esperion Therapeutics, Inc.
$75
Supernus Pharmaceuticals, Inc.
$71
Kowa Pharmaceuticals America, Inc.
$66
Medtronic Vascular, Inc.
$65
Vanda Pharmaceuticals Inc.
$65
ACADIA Pharmaceuticals Inc
$63
Allergan Inc.
$60
Mannkind Corporation
$58
OPKO Pharmaceuticals, LLC
$55
E.R. Squibb & Sons, L.L.C.
$53
Bayer Healthcare Pharmaceuticals Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$33
Biogen, Inc.
$28
Nevro Corp.
$25
Medtronic, Inc.
$25
NESTLE HEALTHCARE NUTRITION INC.
$25
Ultragenyx Pharmaceutical Inc.
$23
ITI, Inc.
$23
INSYS Therapeutics Inc
$22
Scilex Pharmaceuticals Inc.
$22
Inspire Medical Systems, Inc.
$21
Genentech USA, Inc.
$19
Sun Pharmaceutical Industries Inc.
$19
SK Life Science, Inc.
$17
Silk Road Medical, Inc.
$16
Horizon Therapeutics plc
$15
Philips Electronics North America Corporation
$14
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFREZZA · AIRSUPRA · AJOVY · ANORO · APTIOM · AREXVY · AUSTEDO · Advisa · Aimovig · Amitiza · Austedo XR · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BREO · BREZTRI · BYSTOLIC · Briviact · CAPLYTA · CHANTIX · COBENFY · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Crysvita · DUZALLO · Dexilant · ELIQUIS · EMGALITY · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EUCRISA · EVENITY · EZALLOR SPRINKLE · Edarbi · FARXIGA · FLECTOR · FLECTOR PATCH · Fintepla · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · IBSRELA · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MAVYRET · MOTEGRITY · MOUNJARO · MYFEMBREE · Mitigare · Motegrity · Movantik · NEXLETOL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nalocet · Nuedexta · OCREVUS · OFEV · ONGENTYS · Omnia · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · Prolia · QULIPTA · QUVIVIQ · RAYALDEE · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNDROS · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Talicia · Tresiba · Trintellix · UBRELVY · UTIBRON · UTIBRON NEOHALER · Uloric · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Vemlidy · Victoza · Wellcentive Undiv · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZENPEP · ZORYVE · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for geriatric medicine (internal medicine) physician in CA.
Geographic Context
Geriatric medicine physicians within 10 mi
3
Per 100K population
0.4
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kamali is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kamali experienced with office visit, established patient (10-19 min)?
Based on Medicare claims data, Dr. Kamali performed 799 office visit, established patient (10-19 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kamali receive payments from pharmaceutical companies?
Yes. Dr. Kamali received a total of $21,252 from 68 companies across 1,254 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamali's costs compare to other geriatric medicine physicians in Stockton?
Dr. Kamali's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Geriatric Medicine Physicians in Stockton
Browse geriatric medicine physicians in Stockton ranked by procedure volume and transparency data.
Highest volume
Top Geriatric Medicine Physicians in CA
Geriatric medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Geriatric Medicine Physicians in CA
Which CA geriatric medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology